全文获取类型
收费全文 | 47683篇 |
免费 | 5229篇 |
国内免费 | 2476篇 |
专业分类
耳鼻咽喉 | 859篇 |
儿科学 | 1054篇 |
妇产科学 | 394篇 |
基础医学 | 6514篇 |
口腔科学 | 7436篇 |
临床医学 | 4015篇 |
内科学 | 4212篇 |
皮肤病学 | 236篇 |
神经病学 | 1022篇 |
特种医学 | 2192篇 |
外国民族医学 | 25篇 |
外科学 | 9777篇 |
综合类 | 7302篇 |
现状与发展 | 8篇 |
预防医学 | 1434篇 |
眼科学 | 215篇 |
药学 | 2311篇 |
24篇 | |
中国医学 | 1490篇 |
肿瘤学 | 4868篇 |
出版年
2024年 | 133篇 |
2023年 | 815篇 |
2022年 | 1574篇 |
2021年 | 2089篇 |
2020年 | 2057篇 |
2019年 | 1814篇 |
2018年 | 1655篇 |
2017年 | 1841篇 |
2016年 | 1812篇 |
2015年 | 2131篇 |
2014年 | 3091篇 |
2013年 | 4119篇 |
2012年 | 2534篇 |
2011年 | 2901篇 |
2010年 | 2510篇 |
2009年 | 2350篇 |
2008年 | 2246篇 |
2007年 | 2247篇 |
2006年 | 2041篇 |
2005年 | 1960篇 |
2004年 | 1755篇 |
2003年 | 1521篇 |
2002年 | 1306篇 |
2001年 | 1146篇 |
2000年 | 942篇 |
1999年 | 851篇 |
1998年 | 703篇 |
1997年 | 682篇 |
1996年 | 646篇 |
1995年 | 463篇 |
1994年 | 482篇 |
1993年 | 332篇 |
1992年 | 338篇 |
1991年 | 279篇 |
1990年 | 231篇 |
1989年 | 217篇 |
1988年 | 174篇 |
1987年 | 140篇 |
1986年 | 135篇 |
1985年 | 169篇 |
1984年 | 120篇 |
1983年 | 112篇 |
1982年 | 136篇 |
1981年 | 96篇 |
1980年 | 93篇 |
1979年 | 89篇 |
1978年 | 95篇 |
1977年 | 65篇 |
1976年 | 61篇 |
1975年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
22.
C. Banella M. Ginevrino G. Catalano E. Fabiani G. Falconi M. Divona P. Curzi P. Panetta M.T. Voso N.I. Noguera 《Hematology/oncology and stem cell therapy》2021,14(2):163-168
FGFR–TACC, found in different tumor types, is characterized by the fusion of a member of fibroblast grown factor receptor (FGFR) tyrosine kinase (TK) family to a member of the transforming acidic coiled-coil (TACC) proteins. Because chromosome numerical alterations, hallmarks of FGFR–TACC fusions are present in many hematological disorders and there are no data on the prevalence, we studied a series of patients with acute myeloid leukemia and myelodysplastic syndrome who presented numerical alterations using cytogenetic traditional analysis. None of the analyzed samples showed FGFR3–TACC3 gene fusion, so screening for this mutation at diagnosis is not recommended. 相似文献
23.
Yong Luo Yang Zou Li-ping Li Zhao-zhen Wang Li-qun Wang Zi-yu Zhang 《Gynecological endocrinology》2020,36(10):895-901
AbstractOxidative stress (OS) has been proposed to play a role in the development of EMs. Peroxiredoxins are a family of antioxidant proteins that exhibit peroxidase activity in a thioredoxin-dependent manner, protecting cells against OS. The Western blotting results showed that the relative expression of PRDX4 was significantly increased in ectopic endometria compared with the normal endometria of EMs-free (p?<?.05). The H2O2 concentration was also significantly higher in the ectopic endometrium. PRDX4 siRNA was transfected into primary ectopic endometrial stromal cells (EESCs). The viability of the transfected EESCs was measured by CCK-8 assay, and the results showed significantly decreased cell viability. Furthermore, the apoptosis rate and ROS generation in flow cytometry assays were significantly increased after the knockdown of PRDX4 expression (p?<?.05). Scratch assays and transwell assays revealed that decreased expression of PRDX4 mediated by siRNA inhibited EESC migration and invasion. In conclusion, these findings indicate the potential role of PRDX4 in the development of EMs and PRDX4 as a possible therapeutic target for EMs treatment. 相似文献
24.
目的通过建立去势比格犬模型,观察绝经早期腹部脂肪变化规律,并通过对脂肪与骨代谢相关血清学指标的测量与分析,探讨脂肪及骨代谢的关键影响因素。方法选取6只成年雌性比格犬进行去势术,分别在术前、术后4个月、6个月、10个月进行腰椎定量CT(quantatitive computed tomography,QCT)腹部脂肪面积、骨密度(bone mineral density,BMD)、MRI腰椎骨髓脂肪含量及血清学指标的检测,比较不同时间各指标的变化趋势及关系。结果比格犬腹内脂肪面积(visceral fat area,VFA)、皮下脂肪面积(subcutaneous fat area,SFA)、腹部总脂肪面积(total fat area,TFA)在术后6个月、10个月均增加(P0.05),术后10个月VFA增加百分比均值为84.39%,且为三者中最大;术后比格犬BMD并未明显降低。体重、BMD、瘦素(leptin,LP)、VFA、高密度脂蛋白(high-density lipoprotein,HDL)与SFA相关。SFA、体重、低密度脂蛋白(low-density lipoprotein,LDL)、内脏脂肪素(visfatin,VFN)与BMD相关。结论去势比格犬模型可用于研究绝经后雌激素缺乏所引起的脂肪代谢变化,但短期内BMD并未明显丢失,骨、脂肪代谢之间存在交互作用。 相似文献
25.
26.
目的:探讨吉西他滨联合西妥昔单抗对三阴乳腺癌细胞增殖、迁移、侵袭的影响,并对可能的机制进行初步的探究。方法:将实验分为西妥昔单抗组(150 μg · mL-1)、吉西他滨联合用药组(西妥昔单抗150 μg · mL-1,吉西他滨2.8 μg·mL-1)。通过MTT、Transwell实验检测联合用药对MDA-MB-231细胞增殖、迁移、侵袭能力的影响,Western blotting实验检测合用药对MDA-MB-231细胞MMP-9、TIMP-1、p-IkB、NF-kB-p65表达水平的影响。结果:吉西他滨联合西妥昔单抗作用MDA-MB-231细胞后,其生长被不同程度的抑制,抑制率随吉西他滨浓度的增加而增高(P<0.05);联合用药组MDA-MB-231细胞迁移、侵袭数目明显减少(P<0.05),同时MMP-9、p-IkB、NF-kB-p65的表达含量降低,TIMP-1表达含量增加。结论:吉西他滨联合西妥昔单抗对三阴乳腺癌细胞增殖、侵袭、迁移具有抑制作用,并明显抑制MMP-9的表达,其机制可能是通过抑制NF-kB通路实现。 相似文献
27.
֣��ǫ�������̣��Ŷ�ǿ 《中国实用口腔科杂志》2015,8(5):271-273
??Objective To investigate the effect of tooth movement at different time after the repair of alveolar bone defects. Methods Defective alveolar bone model was established on one side in forty white rabbits??which were filled with bone meal and attached with Bio-Gide membrane as experiment sides. The other side was performed routine tooth extraction as control. Track the mandibular second molar in both sides respectively in 1 week??1 month??2 months and 3 months after operation. One month later??the distance between the mandibular second molar and third molar was measured with electronic vernier caliper in the experiment side and control side. The mandibular tissue was made paraffin section and hematoxylin eosin staining. Three views of the periodontal ligament in a third place of the mesial roots of the second molar was randomly chosen to count the total number of osteoclasts. Paired-t test analysis was made to evaluate the displacement of the mandibular second molar in experiment and control side??and to evaluate the number of osteoclasts in two side. Results In Group 1w and Group 1 m??the displacement of the mandibular second molar in experiment group was smaller than that in the control side??P??0.05??. There was no statistical significance in Group 2 m and Group 3 m. The number of osteoclasts in the experiment side was less than the control group in Group 1 w and Group1 m??P??0.05??. No statistical significance in Group 2 m and Group 3 m was found. Conclusion Orthodontic treatment can be performed two months after the repair of alveolar bone defects. 相似文献
28.
Thaís dos Santos Fontes Pereira Carolina Cavalieri Gomes Peter A Brennan Felipe Paiva Fonseca Ricardo Santiago Gomez 《Journal of oral pathology & medicine》2019,48(1):3-9
Fibrous dysplasia is a non‐neoplastic developmental process that affects the craniofacial bones, characterized by painless enlargement as a result of bone substitution by abnormal fibrous tissue. Postzygotic somatic activating mutations in the GNAS1 gene cause fibrous dysplasia and have been extensively investigated, as well as being helpful in the differential diagnosis of the disease. Fibrous dysplasia may involve one (monostotic) or multiple bones (polyostotic), sporadically or in association with McCune‐Albright syndrome, Jeffe‐Lichenstein syndrome, or Mazabreud syndrome. This review summarizes the current knowledge on fibrous dysplasia, emphasizing the value of integrating the understanding of its molecular pathogenesis with the clinical, radiological, and histopathological features. In addition, we address important aspects related to the differential diagnosis and patient management. 相似文献
29.
30.